James Herman

James Herman

University of Pittsburgh

H-index: 162

North America-United States

About James Herman

James Herman, With an exceptional h-index of 162 and a recent h-index of 65 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Cancer Epigenetics, Lung Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development of quality control methods for reliable NGS measurement of methylation in cfDNA

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients

EDRN Lung Team Project 2 validation of molecular biomarkers for the early detection of lung cancer in the setting of indeterminate pulmonary nodules

Randomized placebo-controlled phase II clinical trial on oral supplementation of sulforaphane for 12 months that reduced bronchial Ki-67 index in former smokers at high risk …

Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer

Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers

First integrative oncology clinic in the Veteran Affairs (VA) Pittsburgh healthcare system.

The intersection of neighborhood-level disadvantage and overall lung cancer survival.

James Herman Information

University

Position

___

Citations(all)

149121

Citations(since 2020)

36212

Cited By

131077

hIndex(all)

162

hIndex(since 2020)

65

i10Index(all)

370

i10Index(since 2020)

289

Email

University Profile Page

University of Pittsburgh

Google Scholar

View Google Scholar Profile

James Herman Skills & Research Interests

Cancer Epigenetics

Lung Cancer

Top articles of James Herman

Title

Journal

Author(s)

Publication Date

Development of quality control methods for reliable NGS measurement of methylation in cfDNA

Cancer Research

James C Willey

Erin L Crawford

Daniel J Craig

Thomas M Morrison

Hua-Jun He

...

2024/3/22

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients

American Journal of Hematology

Annie Im

Kevin Quann

Mounzer Agha

Anastasios Raptis

Robert L Redner

...

2024/1/22

EDRN Lung Team Project 2 validation of molecular biomarkers for the early detection of lung cancer in the setting of indeterminate pulmonary nodules

Cancer Research

James C Willey

Eric L Grogan

Stephen A Deppen

James G Herman

Michael N Kammer

...

2024/3/22

Randomized placebo-controlled phase II clinical trial on oral supplementation of sulforaphane for 12 months that reduced bronchial Ki-67 index in former smokers at high risk …

Cancer Research

Jian-Min Yuan

Thomas W Kensler

Sanja Dacic

Douglas J Harman

Renwei Wang

...

2024/3/22

Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer

Cancer Research

Blair V Landon

Kristen A Marrone

Michael J Topper

Akshaya Annapragada

Hua-Ling Tsai

...

2024/3/22

Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers

The Journal of thoracic and cardiovascular surgery

Hannah N Marmor

Michael N Kammer

Stephen A Deppen

Maren Shipe

Valerie F Welty

...

2023/9/1

First integrative oncology clinic in the Veteran Affairs (VA) Pittsburgh healthcare system.

Jocelyn L Tan

Hema Rai

Vida Almario Passero

Jeanne Green

James G Herman

...

2023/6/1

The intersection of neighborhood-level disadvantage and overall lung cancer survival.

Kathleen Kennedy

Ignacio Jusue-Torres

Ian Buller

Emily Rossi

Apurva Mallisetty

...

2023/6/1

Pulmonary circulatory system characteristics are associated with future lung cancer risk

Medical Physics

Jiantao Pu

Andriy Bandos

Tong Yu

Renwei Wang

Jian‐min Yuan

...

2023/12/30

Multiplex Digital Methylation‐Specific PCR for Noninvasive Screening of Lung Cancer

Advanced Science

Yang Zhao

Christine M O'Keefe

Kuangwen Hsieh

Leslie Cope

Sonali C Joyce

...

2023/6

RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitors

Epigenomics

Aiai Gao

Panpan Bai

Meiying Zhang

Yuanxin Yao

James G Herman

...

2023/11

REM-DREAMing: Low-cost digital microfluidic analysis of DNA methylation heterogeneity for enhanced, liquid biopsy-based detection of early-stage lung cancer

Cancer Research

Yang Zhao

Christine M O’Keefe

James G Herman

Thomas R Pisanic

Tza-Huei Wang

2023/4/4

604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated …

Kristen A Marrone

Blair V Landon

Michael J Topper

Hua-Ling Tsai

Archana Balan

...

2023/11/1

Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit

Clinical Cancer Research

Marco A Mascarella

Tolani F Olonisakin

Purva Rumde

Varun Vendra

Melonie A Nance

...

2023/2/16

Methylation of NRIP3 is a synthetic lethal marker for combined PI3K and ATR/ATM inhibitors in CRC

Clinical and Translational Gastroenterology

Meiying Zhang

Xiaoyun Li

James G Herman

Aiai Gao

Qian Wang

...

2022/5/13

Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling

Clinical Epigenetics

Weili Yang

Chao Guo

James G Herman

Cheng Zhu

Honghui Lv

...

2022/12

DNA-methylation for the detection and distinction of 19 human malignancies

Epigenetics

Ludmila Danilova

John Wrangle

James G Herman

Leslie Cope

2022/2/1

Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers

Clinical epigenetics

Maartje Massen

Kim Lommen

Kim AD Wouters

Johan Vandersmissen

Wim Van Criekinge

...

2022/12

A MICROFLUIDIC PLATFORM FOR QUANTITATIVE MULTIPLEX PROFILING OF DNA METHYLATION BIOMARKERS

Yang Zhao

Christine M O'Keefe

James G Herman

Thomas Pisanic

Tza Huei Wang

2022

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

Clinical Epigenetics

Chaoyuan Kuang

Yongseok Park

Ryan C Augustin

Yan Lin

Douglas J Hartman

...

2022/12

See List of Professors in James Herman University(University of Pittsburgh)